Surgical Aortic Valve Replacements in 2010

In 2010, ~67,500 surgical aortic valve replacements (SAVR) were performed in the U.S.

Clinical and Economic Outcomes After Surgical Aortic Valve Replacement in Medicare Patients. Risk Manag Healthc Policy. 2012; 2012(5): 117-26. https://www.dovepress.com/clinical-and-economic-outcomes-after-surgical-aortic-valve-replacement-peer-reviewed-article-RMHP

Title: Clinical and Economic Outcomes After Surgical Aortic Valve Replacement in Medicare Patients
Publication: Risk Manag Healthc Policy
Publication Date: 2012
Volume & Issue: Volume 2012, Issue 5
Pages: 117-26
URL: Read Full Resource

Cost-effectiveness of TAVR in sSAS patients
Patients with severe symptomatic aortic stenosis (sSAS) considered to be at high surgical risk who underwent transcatheter aortic valve replacement (TAVR) experienced lifetime incremental cost-effectiveness ratios of $55,090 per QALY… [ Get More Details ]
TAVR Success in sSAS Patients
A study of severe symptomatic aortic stenosis (sSAS) patients who received transcatheter aortic valve replacement (TAVR) found 30-day mortality of 2.2% for those who were high risk of surgical mortality/inoperable,… [ Get More Details ]
TAVR v. SAVR in Intermediate-Risk SAS Patients
At 1-year, severe aortic stenosis (SAS) patients with intermediate surgical mortality risk who underwent transcatheter aortic valve replacement (TAVR), had all-cause mortality rates of 7.4% (compared to 13% for surgical… [ Get More Details ]
Improvements in QoL from TAVR in SAS patients
Symptomatic aortic stenosis (SAS) patients who underwent transcatheter aortic valve replacement (TAVR) experienced quality of life (QoL) improvements from 5.3 at baseline (10 point scale with 10=best imaginable health state)… [ Get More Details ]
In 2010, ~67,500 SAVRs were performed in the U.S.
[ Get More Details ]